Lung Cancer Screening: The Way Forward

Br J Cancer. 2008 Aug 19;99(4):557-62. doi: 10.1038/sj.bjc.6604509. Epub 2008 Jul 29.

Abstract

To take lung cancer screening into national programmes, we first have to answer the question whether low-dose computed tomography (LDCT) screening and treatment of early lesions will decrease lung cancer mortality compared with a control group, to accurately estimate the balance of benefits and harms, and to determine the cost-effectiveness of the intervention.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cost-Benefit Analysis
  • Humans
  • Lung Neoplasms / diagnostic imaging*
  • Lung Neoplasms / mortality
  • Lung Neoplasms / therapy
  • Mass Chest X-Ray
  • National Health Programs
  • Survival Rate
  • Tomography, X-Ray Computed
  • United Kingdom